OTTAWA, ON, April 1, 2025 /CNW/ -
Summary
Affected products
Unauthorized injectable peptide drugs, including:
• ARA 16
• ARA 290
• BPC-157
• CJC-1295
• DSIP without Mannitol
Read more at newswire.caThis article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.